Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David R Grosshans
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Boca Raton Regional Hospital
Boca Raton, Florida, United States
- Miami Cancer Institute
Miami, Florida, United States
- Emory Proton Therapy Center
Atlanta, Georgia, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Northwestern Medicine Cancer Center Delnor
Geneva, Illinois, United States
- Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- University of Kansas Cancer Center-Overland Park
Overland Park, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas, United States
- Mainehealth Maine Medical Center- Scarborough
Scarborough, Maine, United States
- Maryland Proton Treatment Center
Baltimore, Maryland, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Um Upper Chesapeake Medical Center
Bel Air, Maryland, United States
- Central Maryland Radiation Oncology in Howard County
Columbia, Maryland, United States
- Um Baltimore Washington Medical Center/tate Cancer Center
Glen Burnie, Maryland, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- University of Kansas Cancer Center - North
Kansas City, Missouri, United States
- University of Kansas Cancer Center - Lee'S Summit
Lee's Summit, Missouri, United States
- University of Kansas Cancer Center at North Kansas City Hospital
North Kansas City, Missouri, United States
- Mercy Hospital Springfield
Springfield, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Laura and Isaac Perlmutter Cancer Center at Nyu Langone
New York, New York, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- University Hospitals Parma Medical Center
Parma, Ohio, United States
- University Hospitals Portage Medical Center
Ravenna, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- University of Pennsylvania/abramson Cancer Center
Philadelphia, Pennsylvania, United States
- Ut Md Anderson Cancer Center
Houston, Texas, United States
- Fhcc at Northwest Hospital
Seattle, Washington, United States
- University of Washington Medical Center - Montlake
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jan 2018
- Primary completion
- 15 Jul 2026
- Completion
- 15 Jul 2026
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 120
- Registry id
- NCT03180502
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.